Geoff Randall
Corporate Officer/Principal bei The Marine Biological Laboratory
Profil
Mr. Geoff Randall is Non-Executive Director at Microbial Solutions Ltd.
and Vice President at The Marine Biological Laboratory.
He is on the Board of Directors at Microbial Solutions Ltd.
Mr. Randall was previously employed as a Director-Global Safety by AstraZeneca AB.
He also served on the board at fluXXion BV.
Aktive Positionen von Geoff Randall
Unternehmen | Position | Beginn |
---|---|---|
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Geoff Randall
Unternehmen | Position | Ende |
---|---|---|
fluXXion BV
fluXXion BV SemiconductorsElectronic Technology fluXXion founded in 2003, is a Dutch clean technology company applying proven manufacturing technology from the semiconductor and micro system industries, to the design and manufacture of unique micro filtration and separation products for bulk liquid filtration markets and chemical separation markets. The basic manufacturing technology was originally developed by Royal Philips Electronics in the Netherlands, for the manufacture of complex micro structured products. Co-inventor Prof. Dr. Cees van Rijn first started making wafer based Microsieves for filtration in 1994. fluXXion completed the industrial application of this technology and has its own R&D as well as production facilities. A well-balanced team of industry veterans, who worked together for over ten years in related high technology fields, founded the Company in 2003 and expanded the company over the years. fluXXion is based on the High Tech Campus in Eindhoven, the Netherlands The company has closed several contracts with leading industrial partners to develop, integrate and market the technology. Given the huge benefits of the fluXXion technology versus the traditional filtration and separation technologies, in the focal area's dairy products processing and distillation applications, it is clear that the company has great potential to become an unique major technology provider in these markets. The first full scale filtration plant is in operation at a large cheese factory with an annual capacity of 40 000 tons. A demo-unit for a chemicals stripping unit will be built in the first half of 2010. In 2008 fluXXion was the only Dutch company selected as Technology Pioneer by the World Economic Forum. | Direktor/Vorstandsmitglied | 10.08.2011 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Microbial Solutions Ltd.
Microbial Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Microbial Solutions Limited develops and manufactures bacteria purification technology. The Microcycle technology is a patented biological degradation process that reduces waste MWFs to acceptable COD concentrations, removes toxicity and allows for the safe disposal of MWF as grey water to sewers on site. The company was founded by Christopher J. van der Gast and Ian P. Thompson in December 2007 and is headquartered in Yarnton, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Commercial Services |
fluXXion BV
fluXXion BV SemiconductorsElectronic Technology fluXXion founded in 2003, is a Dutch clean technology company applying proven manufacturing technology from the semiconductor and micro system industries, to the design and manufacture of unique micro filtration and separation products for bulk liquid filtration markets and chemical separation markets. The basic manufacturing technology was originally developed by Royal Philips Electronics in the Netherlands, for the manufacture of complex micro structured products. Co-inventor Prof. Dr. Cees van Rijn first started making wafer based Microsieves for filtration in 1994. fluXXion completed the industrial application of this technology and has its own R&D as well as production facilities. A well-balanced team of industry veterans, who worked together for over ten years in related high technology fields, founded the Company in 2003 and expanded the company over the years. fluXXion is based on the High Tech Campus in Eindhoven, the Netherlands The company has closed several contracts with leading industrial partners to develop, integrate and market the technology. Given the huge benefits of the fluXXion technology versus the traditional filtration and separation technologies, in the focal area's dairy products processing and distillation applications, it is clear that the company has great potential to become an unique major technology provider in these markets. The first full scale filtration plant is in operation at a large cheese factory with an annual capacity of 40 000 tons. A demo-unit for a chemicals stripping unit will be built in the first half of 2010. In 2008 fluXXion was the only Dutch company selected as Technology Pioneer by the World Economic Forum. | Electronic Technology |
Microbial Solutions Ltd.
Microbial Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Microbial Solutions Limited develops and manufactures bacteria purification technology. The Microcycle technology is a patented biological degradation process that reduces waste MWFs to acceptable COD concentrations, removes toxicity and allows for the safe disposal of MWF as grey water to sewers on site. The company was founded by Christopher J. van der Gast and Ian P. Thompson in December 2007 and is headquartered in Yarnton, the United Kingdom. | Commercial Services |